Pharmaceutical

GSK CEO Emma Walmsley Steps Down, Luke Miels Appointed as New CEO

After nearly nine years, Emma Walmsley, the CEO of GSK Plc, is leaving her position. Luke Miels, the chief commercial officer of the British pharmaceutical company, will take over as CEO. After working for other large European pharmaceutical companies, Miels joined GSK in 2017 and is now in charge of

📄Company Profiles

Nveda: Revolutionizing Healthcare with Nutraceutical Solutions

India's Nutritional Supplements Market was valued at U$ 11.85 billion in 2023 and is projected to hit the market valuation of US$ 28.70 billion by 2032 at a CAGR of 10.7% during the forecast period 2024–2032. Nveda is a fast-growing brand engaged in bringing